Literature DB >> 30724698

The role of PAK1 in the sensitivity of kidney epithelial cells to ischemia-like conditions.

Evan R Zynda1, Mitchell H Maloy1, Eugene S Kandel1.   

Abstract

Kidney ischemia, characterized by insufficient supply of oxygen and nutrients to renal epithelial cells, is the main cause of acute kidney injury and an important contributor to mortality world-wide. Earlier research implicated a G-protein coupled receptor (NK1R) in the death of kidney epithelial cells in ischemia-like conditions. P21-associated kinase 1 (PAK1) is involved in signalling by several G-proteins. We explored the consequences of PAK1 inhibition for cell survival under the conditions of reduced glucose and oxygen. Inhibition of PAK1 by RNA interference, expression of a dominant-negative mutant or treatment with small molecule inhibitors greatly reduced the death of cultured kidney epithelial cells. Similar protection was achieved by treating the cells with inhibitors of MEK1, in agreement with the prior reports on PAK1-MEK1 connection. Concomitant inhibition of NK1R and PAK1 offered no better protection than inhibition of NK1R alone, consistent with the two proteins being members of the same pathway. Furthermore, NK1R, PAK and MEK inhibitors reduced the induction of TRAIL in ischemia-like conditions. Considering the emerging role of TRAIL in ischemia-mediated cell death, this phenomenon may contribute to the protective effects of these small molecules. Our findings support further exploration of PAK and MEK inhibitors as possible agents to avert ischemic kidney injury.

Entities:  

Keywords:  Acute kidney injury; MAP kinase cascade; tachykinin receptor 1

Mesh:

Substances:

Year:  2019        PMID: 30724698      PMCID: PMC6464575          DOI: 10.1080/15384101.2019.1578149

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  71 in total

Review 1.  The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades.

Authors:  J S Gutkind
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

Review 2.  International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.

Authors:  Ravindra L Mehta; Jorge Cerdá; Emmanuel A Burdmann; Marcello Tonelli; Guillermo García-García; Vivekanand Jha; Paweena Susantitaphong; Michael Rocco; Raymond Vanholder; Mehmet Sukru Sever; Dinna Cruz; Bertrand Jaber; Norbert H Lameire; Raúl Lombardi; Andrew Lewington; John Feehally; Fredric Finkelstein; Nathan Levin; Neesh Pannu; Bernadette Thomas; Eliah Aronoff-Spencer; Giuseppe Remuzzi
Journal:  Lancet       Date:  2015-03-13       Impact factor: 79.321

3.  DNA damage players are linked to HIF-1α/hypoxia signaling.

Authors:  Abdol-Hossein Rezaeian; Yu-Hui Wang; Hui-Kuan Lin
Journal:  Cell Cycle       Date:  2017-03-10       Impact factor: 4.534

4.  A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery.

Authors:  Patrick Meybohm; Berthold Bein; Oana Brosteanu; Jochen Cremer; Matthias Gruenewald; Christian Stoppe; Mark Coburn; Gereon Schaelte; Andreas Böning; Bernd Niemann; Jan Roesner; Frank Kletzin; Ulrich Strouhal; Christian Reyher; Rita Laufenberg-Feldmann; Marion Ferner; Ivo F Brandes; Martin Bauer; Sebastian N Stehr; Andreas Kortgen; Maria Wittmann; Georg Baumgarten; Tanja Meyer-Treschan; Peter Kienbaum; Matthias Heringlake; Julika Schön; Michael Sander; Sascha Treskatsch; Thorsten Smul; Ewa Wolwender; Thomas Schilling; Georg Fuernau; Dirk Hasenclever; Kai Zacharowski
Journal:  N Engl J Med       Date:  2015-10-05       Impact factor: 91.245

5.  ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells.

Authors:  Shougang Zhuang; Yan Yan; Rebecca A Daubert; Jiahuai Han; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-01

6.  Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells.

Authors:  I Castagliuolo; L Valenick; J Liu; C Pothoulakis
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

7.  The Devil Is in the Detail: Remote Ischemic Preconditioning for Perioperative Kidney Protection.

Authors:  Felix Kork; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2017-05       Impact factor: 7.892

8.  Regulation of hypoxic neuronal death signaling by neuroglobin.

Authors:  Adil A Khan; Xiao Ou Mao; Surita Banwait; Celine M DerMardirossian; Gary M Bokoch; Kunlin Jin; David A Greenberg
Journal:  FASEB J       Date:  2008-01-15       Impact factor: 5.191

9.  Phosphorylation of ERK in neurokinin 1 receptor-expressing neurons in laminae III and IV of the rat spinal dorsal horn following noxious stimulation.

Authors:  Erika Polgár; Annie D Campbell; Lynsey M MacIntyre; Masahiko Watanabe; Andrew J Todd
Journal:  Mol Pain       Date:  2007-02-19       Impact factor: 3.395

10.  Rotenone ameliorates chronic renal injury caused by acute ischemia/reperfusion.

Authors:  Wen Zhang; Yugen Sha; Ke Wei; Chunfeng Wu; Dan Ding; Yunwen Yang; Chunhua Zhu; Yue Zhang; Guixia Ding; Aihua Zhang; Zhanjun Jia; Songming Huang
Journal:  Oncotarget       Date:  2018-05-11
View more
  3 in total

1.  The role of polo-like kinase 3 in the response of BRAF-mutant cells to targeted anticancer therapies.

Authors:  Mahamat Babagana; Julia V Kichina; Hannah Slabodkin; Sydney Johnson; Alexei Maslov; Lorin Brown; Kristopher Attwood; Mikhail A Nikiforov; Eugene S Kandel
Journal:  Mol Carcinog       Date:  2019-09-30       Impact factor: 4.784

2.  Proteotoxic Stress as an Exploitable Vulnerability in Cells with Hyperactive AKT.

Authors:  Mahamat Babagana; Lorin R Brown; Hannah Z Slabodkin; Julia V Kichina; Eugene S Kandel
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

3.  Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A2 suppress prostate cancer growth and metastasis.

Authors:  Arti Verma; Wided Najahi-Missaoui; Brian S Cummings; Payaningal R Somanath
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.